The cervix is the narrow lower portion of the uterus that opens into the vagina. It plays a vital role in reproduction, childbirth, and menstrual flow.

It consists of two main epithelial regions:

• Ectocervix: The outer part of the cervix lined by squamous epithelial cells.
• Endocervix: The inner canal lined by glandular cells.

Between these two regions lies the transformation zone, which is the most vulnerable area for abnormal cellular changes. This zone is the primary site where Cervical Cancer originates, due to active cell turnover and susceptibility to HPV infection.

Understanding this anatomical region is crucial for Pap smear sampling and early detection strategies.

• The primary cause of Cervical Cancer is persistent infection with high-risk strains of Human Papillomavirus (HPV), particularly types 16 and 18.
• HPV is transmitted mainly through sexual contact. In most individuals, the infection clears naturally within months. However, in some cases, the virus persists and integrates into cervical cells, causing genetic alterations.
• Over time, these changes can lead to uncontrolled cell growth and progression toward malignancy.

Cervical cancer develops due to several risk factors that increase the likelihood of persistent HPV infection and abnormal cell changes in the cervix.

• HPV infection: The most important risk factor is long-term infection with high-risk types of Human Papillomavirus (HPV). Persistent infection can lead to abnormal cervical cell changes over time.
• Multiple sexual partners: Having multiple partners increases the chances of exposure to HPV, thereby increasing infection risk.
• Early sexual activity: Starting sexual activity at an early age increases the duration of exposure to HPV, raising the risk of infection.
• Other infections (HIV, chlamydia): These infections weaken the immune system, making it harder for the body to fight HPV effectively.
• Smoking: Tobacco use damages cervical cells and weakens immune defenses, making HPV infection more likely to persist.
• Weak immune system: Conditions that reduce immunity, such as immunosuppressive diseases or medications, reduce the body’s ability to clear HPV infection.
• Long-term use of birth control pills: Prolonged use may slightly increase the risk of cervical cancer, especially when combined with HPV infection.
• No regular screening: Lack of Pap smear or HPV testing allows precancerous changes to remain undetected and progress to cancer.
• Rare exposure to DES: Exposure to diethylstilbestrol (DES) in the womb is a rare but known risk factor for cervical cancer later in life.

The development of Cervical Cancer follows a gradual multi-step process:

• HPV infects cervical epithelial cells
• Viral DNA integrates into host cells
• Abnormal cell changes occur (CIN 1 → CIN 2 → CIN 3)
• Progressive dysplasia over years
• Invasion of basement membrane → invasive cancer

If untreated, cancer can spread locally to surrounding tissues and later metastasize to distant organs.

This long pre-invasive phase is what makes Cervical Cancer one of the most preventable cancers in women.

Cervical cancer is classified based on the type of cells from which it originates. The main types differ in their location, behavior, and frequency.

• Squamous Cell Carcinoma (SCC): This is the most common type of cervical cancer, accounting for about 70–80% of cases. It develops from the squamous epithelial cells that line the outer part of the cervix (ectocervix). SCC usually begins in the transformation zone and is strongly associated with HPV infection.
• Adenocarcinoma: This type arises from the glandular cells of the endocervix (inner cervical canal). It is less common than SCC but has been increasing in incidence. Adenocarcinoma may be harder to detect early through screening because it develops higher inside the cervical canal.
• Adenosquamous Carcinoma: This is a mixed type of cancer that contains both squamous and glandular cell features. It is less common and may behave more aggressively than the individual types.
• Rare Variants: These include uncommon forms such as small cell carcinoma and neuroendocrine tumors. They are rare but tend to grow quickly and are often more aggressive compared to the common types.

Each type has different biological behavior and treatment response.

Early Stage Cervical Cancer:

Often asymptomatic, which is why screening is essential.

Later Symptoms:

1. Abnormal vaginal bleeding
   • After intercourse
   • Between menstrual cycles
   • After menopause
2. Unusual watery or foul-smelling vaginal discharge
3. Pelvic pain
4. Pain during intercourse (dyspareunia)

Advanced Disease:

• Weight loss and fatigue
• Lower back or leg pain
• Urinary symptoms (hematuria, obstruction)
• Bowel symptoms in severe cases

Screening is one of the most effective methods for preventing cervical cancer because it helps detect abnormal changes in cervical cells at an early, treatable stage before cancer develops. Early detection greatly reduces the risk of progression and lowers mortality rates.

• The Pap smear (cytology test) is a widely used screening method that collects cells from the cervix and examines them under a microscope to identify any abnormal or precancerous changes. It is simple, quick, and highly effective in detecting early lesions.
• The HPV DNA test is another important screening tool that detects the presence of high-risk Human Papillomavirus strains responsible for cervical cancer. It helps identify women at higher risk even before cellular changes occur.
• Co-testing, which combines both Pap smear and HPV testing, provides the highest accuracy for early detection.

Regular and routine screening allows identification of precancerous conditions at an early stage, enabling timely treatment and significantly reducing the chances of developing cervical cancer.

If screening results are abnormal, further diagnostic steps include:

• Pelvic examination
• Colposcopy (magnified cervical examination)
• Cervical biopsy (gold standard for confirmation)

Imaging for staging and spread:

• MRI (best for pelvic evaluation)
• CT scan
• PET scan
• X-rays in advanced cases

A multidisciplinary diagnostic approach ensures accurate staging and treatment planning.

In many tertiary care centers such as Kannappa Hospital Memorial, advanced diagnostic facilities are used to ensure early and precise detection of Cervical Cancer.

Staging of cervical cancer describes how far the disease has spread in the body. It is an important step because it helps doctors decide the most appropriate treatment and predict the outcome of the disease.

Stage I: The cancer is limited to the cervix only. It has not spread to nearby tissues or organs. This stage often has the best prognosis because the disease is detected early.

Stage II: The cancer has spread beyond the cervix to nearby tissues, but it has not reached the pelvic wall or the lower part of the vagina. At this stage, the disease is more advanced but still considered potentially curable.

Stage III: The cancer extends to the pelvic wall and/or involves nearby lymph nodes. It may also affect the lower part of the vagina and can start to interfere with kidney function due to blockage of urinary flow.

Stage IV: This is the most advanced stage. The cancer spreads to nearby organs such as the bladder or rectum (Stage IVA) or to distant organs like the lungs, liver, or bones (Stage IVB). Treatment at this stage is mainly focused on control of symptoms and improving quality of life.

Accurate staging is essential for choosing the right treatment plan and improving patient outcomes.

 Treatment depends on the stage of the disease and the patient’s overall condition.

• Early stage: Surgical options such as conization, hysterectomy, and trachelectomy (fertility-preserving surgery) may be used.
• Locally advanced disease: Treatment usually involves radiotherapy combined with chemotherapy.
• Advanced or metastatic disease: Management includes systemic chemotherapy, immunotherapy (checkpoint inhibitors), targeted therapy, and palliative care to relieve symptoms.

Modern oncology focuses on individualized treatment plans to improve both survival and quality of life.

Prevention is the most effective strategy against Cervical Cancer.

Primary Prevention:

• HPV vaccination: Protects against the virus that causes cervical cancer.
• Safe sexual practices: Using protection (like condoms) helps reduce infection risk.
• Limiting sexual partners: Fewer partners lowers the chance of HPV exposure.
• Avoiding smoking: Smoking weakens the body’s defense and increases cancer risk.

Secondary Prevention:

• Regular Pap smear screening: Helps find early abnormal changes in cervical cells before cancer develops.
• HPV DNA testing: Detects high-risk HPV infection that can lead to cervical cancer.
• Treatment of precancerous lesions (CIN): Treating early cell changes prevents them from turning into cancer.

Vaccination programs combined with screening have significantly reduced incidence in many countries.

The prognosis of Cervical Cancer depends largely on the stage at diagnosis:

• Early-stage disease: excellent survival rates (often >90%)
• Locally advanced disease: moderate prognosis
• Metastatic disease: lower survival rates

Early detection remains the most important determinant of survival outcomes.

Cervical Cancer is:

• The 4th most common cancer in women worldwide
• A leading cause of cancer-related deaths among women in low- and middle-income countries
• Strongly associated with lack of screening and limited HPV vaccination coverage

Global health initiatives aim to eliminate Cervical Cancer through vaccination, screening, and treatment accessibility.

Cervical Cancer is one of the most preventable and treatable cancers when detected early. The strong association with HPV infection provides a clear pathway for prevention through vaccination and regular screening.Public awareness, early diagnosis, and timely medical intervention are essential to reducing its burden. Healthcare institutions and community-level programs play a vital role in improving outcomes.

Hospitals such as Kannappa Hospital Memorial contribute significantly by offering screening services, diagnostic accuracy, and comprehensive cancer care support.